Related references
Note: Only part of the references are listed.Molecular Variants in Human Trace Amine-Associated Receptors and Their Implications in Mental and Metabolic Disorders
Grazia Rutigliano et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2020)
Actions of Trace Amines in the Brain-Gut-Microbiome Axis via Trace Amine-Associated Receptor-1 (TAAR1)
Katlynn Bugda Gwilt et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2020)
Trace amine associated receptor 1 (TAAR1) modulators: a patent review (2010-present)
Michele Tonelli et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2020)
Trace Amine-Associated Receptor 5 Provides Olfactory Input Into Limbic Brain Areas and Modulates Emotional Behaviors and Serotonin Transmission
Stefano Espinoza et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?
Grazia Rutigliano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
A Non-D2-Receptor-Binding Drug for the Treatment of Schizophrenia
Kenneth S. Koblan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Promising Evidence of Antipsychotic Efficacy without Dopamine D2-Receptor Binding
Donald C. Goff
NEW ENGLAND JOURNAL OF MEDICINE (2020)
SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D2 Receptor Mechanism of Action
Nina Dedic et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Trace amine associated receptor 1 (TAAR1) expression and modulation of inflammatory cytokine production in mouse bone marrow-derived macrophages: a novel mechanism for inflammation in ulcerative colitis
Katlynn Bugda Gwilt et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2019)
Non-Functional Trace Amine-Associated Receptor 1 Variants in Patients With Mental Disorders
Grazia Rutigliano et al.
FRONTIERS IN PHARMACOLOGY (2019)
Trace amine-associated receptor gene polymorphism increases drug craving in individuals with methamphetamine dependence
Jennifer M. Loftis et al.
PLOS ONE (2019)
3-IodothyronamineA Thyroid Hormone Metabolite With Distinct Target Profiles and Mode of Action
Josef Koehrle et al.
ENDOCRINE REVIEWS (2019)
Opportunities and challenges in the design of selective TAAR1 agonists: an editorial
Elena Cichero
EXPERT OPINION ON THERAPEUTIC PATENTS (2018)
Trace Amines and Their Receptors
Raul R. Gainetdinov et al.
PHARMACOLOGICAL REVIEWS (2018)
TAAR1 in Addiction: Looking Beyond the Tip of the Iceberg
Jian-Feng Liu et al.
FRONTIERS IN PHARMACOLOGY (2018)
The Case for TAAR1 as a Modulator of Central Nervous System Function
Grazia Rutigliano et al.
FRONTIERS IN PHARMACOLOGY (2018)
Biochemical and Functional Characterization of the Trace Amine-Associated Receptor 1 (TAAR1) Agonist RO5263397
Stefano Espinoza et al.
FRONTIERS IN PHARMACOLOGY (2018)
Review and Meta-Analyses of TAAR1 Expression in the Immune System and Cancers
Lisa M. Fleischer et al.
FRONTIERS IN PHARMACOLOGY (2018)
Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges
Mark D. Berry et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Investigation of Naturally Occurring Single-Nucleotide Variants in Human TAAR1
Jessica Muhlhaus et al.
FRONTIERS IN PHARMACOLOGY (2017)
Methamphetamine induces trace amine-associated receptor 1 (TAAR1) expression in human T lymphocytes: role in immunomodulation
Uma Sriram et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications
Yue Pei et al.
FRONTIERS IN NEUROSCIENCE (2016)
Incretin-like effects of small molecule trace amine-associated receptor 1 agonists
Susanne Raab et al.
MOLECULAR METABOLISM (2016)
Genetic Polymorphisms Affect Mouse and Human Trace Amine-Associated Receptor 1 Function
Xiao Shi et al.
PLOS ONE (2016)
Trace Amine-Associated Receptor 1 Regulation of Methamphetamine Intake and Related Traits
John H. Harkness et al.
NEUROPSYCHOPHARMACOLOGY (2015)
A UGT2B10 Splicing Polymorphism Common in African Populations May Greatly Increase Drug Exposure
Stephen Fowler et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Methamphetamine and HIV-1-induced neurotoxicity: Role of trace amine associated receptor 1 cAMP signaling in astrocytes
Irma E. Cisneros et al.
NEUROPHARMACOLOGY (2014)
Effects of the Trace Amine-Associated Receptor 1 Agonist RO5263397 on Abuse-Related Effects of Cocaine in Rats
David A. Thorn et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Trace Amine-Associated Receptor 1 Partial Agonism Reveals Novel Paradigm for Neuropsychiatric Therapeutics
Florent G. Revel et al.
BIOLOGICAL PSYCHIATRY (2012)
Trace Amine Associated Receptor 1 Signaling in Activated Lymphocytes
Michael W. Panas et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Selective antagonists of mouse trace amine-associated receptor 1 (mTAAR1): Discovery of EPPTB (RO5212773)
Henri Stalder et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Functional Interaction between Trace Amine-Associated Receptor 1 and Dopamine D2 Receptor
Stefano Espinoza et al.
MOLECULAR PHARMACOLOGY (2011)
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity
Florent G. Revel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Functional evolution of the trace amine associated receptors in mammals and the loss of TAAR1 in dogs
Eric J. Vallender et al.
BMC EVOLUTIONARY BIOLOGY (2010)
Trace amine-associated receptor 1 modulates dopaminergic activity
Lothar Lindemann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
The trace amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia
T. D. Wolinsky et al.
GENES BRAIN AND BEHAVIOR (2007)
Trace amine-associated receptor 1 is a modulator of the dopamine transporter
Zhihua Xie et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Trace amine-associated receptors and their ligands
R. Zucchi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor
JR Bunzow et al.
MOLECULAR PHARMACOLOGY (2001)
Share Paper
